A seamless phase II/III design with dose optimization for oncology drug development

DOI10.1002/sim.10129zbMATH Open1545.62436MaRDI QIDQ6618336

Yiding Zhang, Gu Mi, Yu-Han Li, Unnamed Author

Publication date: 14 October 2024

Published in: Statistics in Medicine (Search for Journal in Brave)

zbMATH Keywords

oncologydose optimizationproject optimussample-size re-estimationseamless design

Mathematics Subject Classification ID

Applications of statistics to biology and medical sciences; meta analysis (62P10)

Cites Work

• Dose-Finding Based on Efficacy-Toxicity Trade-Offs
• Sample size re‐estimation in clinical trials
• DROID: dose-ranging approach to optimizing dose in oncology drug development

This page was built for publication: A seamless phase II/III design with dose optimization for oncology drug development